Review
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jan 14, 2015; 21(2): 408-422
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.408
Table 3 Meta-analyses on the treatment of chronic hepatitis C in hemodialysis patients
Ref.YearTrials (n)TherapynSVR1
Russo et al[95]200311IFN21333% (21%-51%)
Fabrizi et al[96]200314IFN26937% (28%-48%)
Gordon et al[97]200820IFN45941% (33%-49%)
5PEG-IFN8737% (9%-77%)
Fabrizi et al[99]200824IFN52939% (32%-46%)
4PEG-IFN11631% (7%-55%)
Gordon et al[98]200920IFN42845%
Alavian et al[100]201021IFN49139% (32%-46%)
12PEG-IFN27939% (27%-52%)
Fabrizi et al[101]201016PEG-IFN25433% (24%-43%)
Fabrizi et al[102]201110PEG-IFN + RBV15156% (28%-84%)
Fabrizi et al[103]201411PEG-IFN + RBV28760% (28%-97%)